Cite

HARVARD Citation

    Edelweiss, M. et al. (2019). HER2 assessment by bright‐field dual in situ hybridization in cell blocks of recurrent and metastatic breast carcinoma. Cancer cytopathology. 127 (11), pp. 684-690. [Online]. 
  
Back to record